Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Consultant Urologist at the Urology and Nephrology Center of Excellence at the Korle Bu Teaching Hospital (KBTH), Dr Isaac ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...

At the ESMO 2025 annual meeting, Dr. Hansen and colleagues presented the first-in-human data of 212 Pb-ADVC001 in patients ...

That’s because most cases are caught before the cancer has spread. In fact, more than 75% of diagnoses are made while the disease is still confined to the prostate. When that happens, the outlook is ...